ERAP1 and infectious disease: However, our identification and experimental validation of a nonsynonymous variant in ERAP1 as a major regulator of IAV in cells and humans underscores that despite noncoding variants receiving much attention as accounting for most of the identified GWAS risk alleles of common diseases,71 coding variation should not be ignored when trying to understand human genetic susceptibility to infectious diseases.